Drug Discovery 아웃소싱 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global drug discovery outsourcing market size is expected to reach USD 10.15 Billion in 2034 from USD 5.02 Billion in 2025, growing at a CAGR of 8.14 during 2026-2034.This market is witnessing rapid expansion as pharmaceutical and biotechnology companies increasingly rely on outsourcing partners to accelerate research and reduce operational costs. Rising demand for novel therapeutics, growing complexity in drug development, and the need for specialized expertise are encouraging companies to collaborate with contract research organizations. Advancements in artificial intelligence, high-throughput screening, and data analytics are also improving efficiency in drug discovery activities, supporting overall market growth across developed and emerging economies.

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is driving investment in innovative drug development programs. Pharmaceutical firms are outsourcing preclinical studies, target identification, and clinical trial support to improve productivity and shorten development timelines. Growing pressure to launch cost-effective medicines and maintain competitive pipelines is further boosting demand for outsourcing services. In addition, favorable government initiatives supporting pharmaceutical innovation are positively influencing market expansion worldwide.

Future prospects for the market remain highly promising due to continuous technological advancements and rising investments in precision medicine and biologics. Emerging economies are expected to become major outsourcing hubs because of lower operational costs and skilled scientific talent. Increasing adoption of cloud-based research platforms and automation technologies will further improve collaboration and data management. As pharmaceutical companies continue focusing on faster drug approvals and research efficiency, the market is expected to witness sustained long-term growth globally.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Workflow

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development

By Therapeutic Area

• Respiratory System Disorders
• Pain and Anesthesia
• Oncology Disorders
• Ophthalmology Disorders
• Hematology Disorders
• Cardiovascular Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Immunomodulation Disorders
• Anti-Infective
• Central Nervous System Disorders
• Dermatology Disorders
• Genitourinary System Disorders

By Drug Type

• Small Molecules
• Large Molecules (Biologics)

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Others

COMPANIES PROFILED

• Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd., Pharmaron Beijing Co. Ltd., Evotec SE, Curia Global Inc., GenScript Biotech Corporation, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Merck & Co. Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Workflow
• 4.2. Target Identification & Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Target Validation & Functional Informatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lead Identification & Candidate Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Preclinical Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapeutic Area
• 5.2. Respiratory System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain and Anesthesia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Oncology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Ophthalmology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hematology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Endocrine Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Gastrointestinal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Immunomodulation Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Anti-Infective Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Central Nervous System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Dermatology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.14. Genitourinary System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Small Molecules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Large Molecules (Biologics) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Workflow
  • 8.2.2 By Therapeutic Area
  • 8.2.3 By Drug Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Workflow
  • 8.3.2 By Therapeutic Area
  • 8.3.3 By Drug Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Workflow
  • 8.4.2 By Therapeutic Area
  • 8.4.3 By Drug Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Workflow
  • 8.5.2 By Therapeutic Area
  • 8.5.3 By Drug Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Workflow
  • 8.6.2 By Therapeutic Area
  • 8.6.3 By Drug Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY OUTSOURCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Charles River Laboratories International Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 WuXi AppTec Co. Ltd
  • 10.2.4 Pharmaron Beijing Co. Ltd
  • 10.2.5 Evotec SE
  • 10.2.6 Curia Global Inc
  • 10.2.7 GenScript Biotech Corporation
  • 10.2.8 Laboratory Corporation Of America Holdings
  • 10.2.9 Eurofins Scientific SE
  • 10.2.10 Merck & Co. Inc